Skip to main content
SpringerLink
Log in

Recombinant Relaxin

A Review of Pharmacology and Potential Therapeutic Use

  • Review Article
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

Use of recombinant relaxin in the treatment of systemic sclerosis (or sclero-derma) has been explored and determined as ineffective. However, continued research has revealed that relaxin is not limited to its role as a hormone. Relaxin has also been shown to decrease collagen formation and secretion, increase collagenase production, influence renal vasodilation, increase vascular endothelial growth factor expression and angiogenesis, promote dilation of blood vessels, and inhibit release of histamine. Further studies to discover other potential uses of relaxin are well-justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bani D. Relaxin: a pleiotropic hormone. Gen Pharmacol 1997; 28(1): 13–22

    Article  PubMed  CAS  Google Scholar 

  2. Klonisch T, Mathias S, Cambridge G, et al. Placental localization of relaxin in the pregnant mare. Placenta 1997; 18(2-3): 121–8

    Article  PubMed  CAS  Google Scholar 

  3. Ghosh D, Stewart DR, Nayak NR, et al. Serum concentrations of oestradial-17beta, progesterone, relaxin and chorionic gonadotrophin during blastocyst implantation in natural pregnancy cycle and in embryo transfer cycle in the rhesus monkey. Hum Reprod 1997; 12(5): 914–20

    Article  PubMed  CAS  Google Scholar 

  4. Ohleth KM, Zhang Q, Bagnell CA. Relaxin protein and gene expression in ovarian follicles of immature pigs. J Mol Endocrinol 1998; 21(2): 179–87

    Article  PubMed  CAS  Google Scholar 

  5. Seibold JR, Clements PJ, Furst DE, et al. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. J Rheumatol 1998; 25: 2

    Google Scholar 

  6. Seibold JR, Korn JH, Simms R, et al. Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 132(11): 871–9

    PubMed  CAS  Google Scholar 

  7. Brennand JE, Calder AA, Leitch CR, et al. Recombinant human relaxin as a cervical ripening agent. Br J Obstet Gynaecol 1997; 104(7): 775–80

    Article  PubMed  CAS  Google Scholar 

  8. Weiss M, Nagelschmidt M, Struck H. Relaxin and collagen metabolism. Horm Metab Res 1979; 11(6): 408–10

    Article  PubMed  CAS  Google Scholar 

  9. Unemori EN, Beck LS, Lee WP, et al. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol 1993; 101(3): 280–5

    Article  PubMed  CAS  Google Scholar 

  10. Unemori EN, Amento EP. Relaxin modulates synthesis and secretion of procollagense and collagen by human dermal fibroblasts. J Biol Chem 1990; 265(18): 10681–5

    PubMed  CAS  Google Scholar 

  11. Unemori EN, Bauer EA, Amento EP. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol 1992; 99(3): 337–42

    Article  PubMed  CAS  Google Scholar 

  12. Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: structure and function. Placenta 1998; 19: 1–11

    Article  PubMed  CAS  Google Scholar 

  13. Millar LK, Boesche MH, Yamamoto SY, et al. A relaxin-mediated pathway to preterm premature rupture of the fetal membranes that is independent of infection. Am J Obstet Gynecol 1998; 179: 126–34

    Article  PubMed  CAS  Google Scholar 

  14. Tozzi CA, Poiani GJ, McHugh NA, et al. Relaxin reduces hypoxia induced pulmonary hypertension in the rat. Am J Respir Crit Care Med 2000; 161: A641

    Google Scholar 

  15. Wahab IM, Anderson RR. Physiologic role of relaxin on mammary gland growth in rats. Proc Soc Exp Biol Med 1989; 192(3): 285–9

    PubMed  CAS  Google Scholar 

  16. Frieden EH, Adams WC. Stimulation of rat uterine collagen synthesis by relaxin. Proc Soc Exp Biol Med 1985; 180(1): 39–43

    PubMed  CAS  Google Scholar 

  17. Hunag C, Li Y, Anderson LL. Stimulation of collagen secretion by relaxin and effect of oestrogen on relaxin binding in uterine cervical cells of pigs. J Reprod Fertil 1993; 98(1): 153–8

    Article  Google Scholar 

  18. Unemori EN, Erikson ME, Rocco SE, et al. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod 1999; 14(3): 800–6

    Article  PubMed  CAS  Google Scholar 

  19. Ohleth KM, Lenhart JA, Ryan PL, et al. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology 1997; 138(9): 3652–8

    Article  PubMed  CAS  Google Scholar 

  20. Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999; 103(4): 525–33

    Article  PubMed  CAS  Google Scholar 

  21. Tseng L, Zhu H, Mazella J, et al. Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells. Mol Hum Reprod 1999; 5(4): 372–5

    Article  PubMed  CAS  Google Scholar 

  22. Stewart D, Erikson M, Erikson M, et al. The role of relaxin in glycodelin secretion. J Clin Endocrinol Metab 1997; 82(3): 839–46

    Article  PubMed  CAS  Google Scholar 

  23. Masini E, Bani D, Bigazzi M, et al. Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J Clin Invest 1994; 94(5): 1974–80

    Article  PubMed  CAS  Google Scholar 

  24. Arnold G, Guzman K, Chao J, et al. Systemic administration of recombinant human relaxin stimulates impaired wound healing. Inflamm Res 2000; 49(Suppl. 2): S93

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Virginia Mason Research Center, 1201 9th Ave, R1-RHE, Seattle, 98101, WA, USA

    Emma S. Gavino & Daniel E. Furst

Authors
  1. Emma S. Gavino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel E. Furst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emma S. Gavino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gavino, E.S., Furst, D.E. Recombinant Relaxin. BioDrugs 15, 609–614 (2001). https://doi.org/10.2165/00063030-200115090-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200115090-00005

Keywords

Search

Navigation